3rd Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$1,380,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to the reimbursement of influenza vaccines in the Medicare Part B program

LobbyistCovered position, as disclosed
SALLY CANFIELD —
MARK COIN —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
PETER RUBIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit and all such provisions in HR422 "To amend the Internal Revenue Code of 1986 to extend research credit through 2010 and to increase and make permanent the alternative simplified research credit'; and S1203 "Grow Research Opportunities with Tax Credits' Help Act" or "GROWTH Act."

LobbyistCovered position, as disclosed
PATRICK MAYES MCLAIN —
PETER RUBIN —
ANN TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 422 (111th)

Copyright/Patent/Trademark CPT

All provisions of S369 "Preserve Access to Affordable Generics Act" and including this bill as amended to be included in S3677 "Financial Services and General Government Appropriations Act, 2011"; and S515 " Patent Reform Act of 2009" - all provisions.

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
EDDIE D EVANS —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
PETER RUBIN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Comparative effectiveness research, including issues related to the Patient Centered Research Institute, and general issues regarding the implementation of HR3590 "The Patient Protection and Affordable Care Act"; information and awareness of the availability of new treatment options for cancer patients; prescription drug safety and heparin including related issues through a follow-on biologics regulatory pathway; issues related to influenza vaccine coverage in the Medicare Part D program; awareness and issues related to patient Access to diabetes care

LobbyistCovered position, as disclosed
SALLY CANFIELD —
TIMOTHY CLARK —
MARK COIN —
EDWARD GREISSING —
PATRICK MAYES MCLAIN —
PETER RUBIN —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.